Wells Fargo analyst
had a target was $17-22 US. ($22-28 cdn.)
---that would be 10-30% lower from here.
---their pipeline of drugs going forward unimpressive
---asset sales self-defeating.
---distressed seller. Buyers will see VRX coming a mile away.
---Jim Chanos (VC) said...'if the companies that Pearson bought awhile ago are not worth double now then VRX is worth 0.
---business model broken & those in charge are not the type to take the company in a different direction (organic growth) successfully
---I don't see VRX surviving this.
carlos